(Q37792762)

23 August 2017

title

Recognizing gastrointestinal and hepatic manifestations of primary immunodeficiency diseases (English)

1 reference

23 August 2017

Recognizing Gastrointestinal and Hepatic Manifestations of Primary Immunodeficiency Diseases (English)

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

20 July 2024

Maria Oliva-Hemker

4

0 references

Anthony L Guerrerio

1

object named as

Anthony L. Guerrerio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20871412

Pamela A Frischmeyer-Guerrerio

20 July 2024

2

object named as

Anthony L. Guerrerio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20871412

20 July 2024

author name string

Pamela A Frischmeyer-Guerrerio

2

1 reference

23 August 2017

Howard M Lederman

3

1 reference

23 August 2017

Pamela A. Frischmeyer-Guerrerio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20871412

20 July 2024

Howard M. Lederman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20871412

20 July 2024

language of work or name

English

0 references

publication date

1 November 2010

1 reference

Journal of Pediatric Gastroenterology and Nutrition

23 August 2017

published in

1 reference

23 August 2017

volume

51

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

548-555

1 reference

Primary immunodeficiencies: 2009 update

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Common variable immunodeficiency: clinical and immunological features of 248 patients.

20 July 2024

2

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Infections in 252 patients with common variable immunodeficiency

20 July 2024

3

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Long-Term Follow-Up and Outcome of a Large Cohort of Patients with Common Variable Immunodeficiency

20 July 2024

4

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency

20 July 2024

5

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Diagnostic findings in 95 Finnish patients with common variable immunodeficiency

20 July 2024

7

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Common variable immunodeficiency: 20-yr experience at a single centre

20 July 2024

8

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review

20 July 2024

9

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Gastrointestinal manifestations in patients with common variable immunodeficiency.

20 July 2024

10

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients

20 July 2024

11

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia

20 July 2024

12

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Gastric pathology in patients with common variable immunodeficiency

20 July 2024

13

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Primary immunodeficiency diseases and cancer: the immunodeficiency-cancer registry

20 July 2024

14

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study

20 July 2024

15

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Idiopathic late-onset immunoglobulin deficiency. Clinical observations in 50 patients

20 July 2024

16

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Prospective study of cancer in patients with hypogammaglobulinaemia

20 July 2024

18

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Hepatitis in common variable immunodeficiency

20 July 2024

19

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Lymphoproliferative disease in antibody deficiency: a multi-centre study

20 July 2024

20

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Physiology of IgA and IgA deficiency

20 July 2024

21

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Selective IgA deficiency in early life: Association to infections and allergic diseases during childhood

20 July 2024

22

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Susceptibility to infections in children with selective IgA- and IgA-IgG subclass deficiency

20 July 2024

23

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

IgA deficiency in children: A clinical study with special reference to intestinal findings

20 July 2024

24

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Primary immunodeficiency syndrome in Japan. I. Overview of a nationwide survey on primary immunodeficiency syndrome

20 July 2024

26

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Primary immunodeficiency disorders in Sweden: Cases among children, 1974?1979

20 July 2024

27

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Primary immunodeficiency syndromes in Italy: a report of the national register in children and adults

20 July 2024

28

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children

20 July 2024

29

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

IgA deficiency: correlation between clinical and immunological phenotypes.

20 July 2024

30

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Clinical manifestations in selective IgA deficiency in childhood. A follow-up report

20 July 2024

31

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Selective IgA deficiency: clinical and immunological evaluation of 50 pediatric patients

20 July 2024

33

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Correlation of milk precipitins with IgA deficiency.

20 July 2024

34

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Burden of allergic disease in the UK: secondary analyses of national databases

20 July 2024

35

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Levels of immunoglobulin G, M, A, and E at various ages in allergic and nonallergic black and white individuals

20 July 2024

36

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Comparison of the frequency of atopic diseases in children with severe and partial IgA deficiency

20 July 2024

37

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Serum Immunoglobulins in Systemic Lupus Erythematosus

20 July 2024

39

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Systemic lupus erythematosus and IgA deficiency

20 July 2024

40

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Selective IgA deficiency and systemic lupus erythematosus

20 July 2024

41

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Antibodies to nucleic acids in congenital immune deficiency states

20 July 2024

42

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Juvenile rheumatoid arthritis--a serologic survey of 200 consecutive patients

20 July 2024

43

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Juvenile rheumatoid arthritis. Cellular hypersensitivity and selective IgA deficiency

20 July 2024

44

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Levels of serum immunoglobulins in juvenile rheumatoid arthritis

20 July 2024

45

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

IgA deficiency in juvenile chronic polyarthritis

20 July 2024

46

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Persistent and transient IgA deficiency in juvenile rheumatoid arthritis

20 July 2024

47

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Celiac disease and selective immunoglobulin A deficiency

20 July 2024

49

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Celiac sprue and immunodeficiency states: a 25-year review

20 July 2024

50

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Celiac disease and IgA deficiency: complications of serological testing approaches encountered in the clinic

20 July 2024

51

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency

20 July 2024

52

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Immunohistochemical findings in the intestine of IgA-deficient persons: number of intraepithelial T lymphocytes is increased

20 July 2024

54

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Prevalence and diagnosis of celiac disease in IgA-deficient children

20 July 2024

55

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Progression of Selective IgA Deficiency to Common Variable Immunodeficiency

20 July 2024

57

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Evolution of IgA deficiency to IgG subclass deficiency and common variable immunodeficiency

20 July 2024

58

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Development of a common variable immunodeficiency in IgA-deficient patients

20 July 2024

59

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Progressive immunodeficiency in a patient with IgA deficiency

20 July 2024

60

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)

20 July 2024

61

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Chronic granulomatous disease. Report on a national registry of 368 patients

20 July 2024

62

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

A fatal granulomatosus of childhood: the clinical study of a new syndrome

20 July 2024

63

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

A Fatal Granulomatous Disease of Childhood

20 July 2024

64

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Chronic granulomatous disease: the European experience

20 July 2024

65

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden.

20 July 2024

66

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan

20 July 2024

67

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Long-term follow-up and outcome of 39 patients with chronic granulomatous disease.

20 July 2024

68

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study

20 July 2024

69

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Chronic granulomatous disease in pediatric patients: 25 years of experience.

20 July 2024

70

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients

20 July 2024

71

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry

20 July 2024

72

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease

20 July 2024

73

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Hepatic abnormalities in patients with chronic granulomatous disease

20 July 2024

74

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Isolation of a novel gene mutated in Wiskott-Aldrich syndrome

20 July 2024

75

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

The Wiskott-Aldrich syndrome

20 July 2024

78

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979).

20 July 2024

79

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients

20 July 2024

80

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

A multiinstitutional survey of the Wiskott-Aldrich syndrome.

20 July 2024

81

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

20 July 2024

82

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Control of regulatory T cell development by the transcription factor Foxp3

20 July 2024

83

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

An essential role for Scurfin in CD4+CD25+ T regulatory cells

20 July 2024

84

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation

20 July 2024

85

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

20 July 2024

86

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy

20 July 2024

87

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome

20 July 2024

88

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome

20 July 2024

89

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity.

20 July 2024

90

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome

20 July 2024

91

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX)

20 July 2024

92

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy.

20 July 2024

93

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature

20 July 2024

94

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

A remarkable depletion of both naïve CD4+ and CD8+ with high proportion of memory T cells in an IPEX infant with a FOXP3 mutation in the forkhead domain.

20 July 2024

95

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Neonatal diabetes mellitus, enteropathy, thrombocytopenia, and endocrinopathy: Further evidence for an X-linked lethal syndrome.

20 July 2024

96

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

X-linked immune dysregulation, neonatal insulin dependent diabetes, and intractable diarrhoea

20 July 2024

97

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Clinical and molecular findings in IPEX syndrome

20 July 2024

98

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Treatment of the Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome (IPEX) by Allogeneic Bone Marrow Transplantation

20 July 2024

99

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome).

20 July 2024

100

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Prospective immunological profiling in a case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX).

20 July 2024

101

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome

20 July 2024

102

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome

20 July 2024

103

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

An infant with erythroderma, skin scaling, chronic emesis, and intractable diarrhea

20 July 2024

104

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene

20 July 2024

105

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Digestive histopathological presentation of IPEX syndrome

20 July 2024

106

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

Manifestations and long-term outcome of food allergy in children after solid organ transplantation

20 July 2024

107

1 reference

https://api.crossref.org/works/10.1097/MPG.0B013E3181EFE56B

20 July 2024

Identifiers

1 reference

23 August 2017

1 reference